Becton, Dickinson & Co. (BDX)
215.71
+1.19
(+0.55%)
USD |
NYSE |
Nov 12, 16:00
215.71
0.00 (0.00%)
Pre-Market: 20:00
Becton, Dickinson Enterprise Value : 74.08B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 74.08B |
| November 11, 2026 | 73.76B |
| November 10, 2026 | 73.24B |
| November 09, 2026 | 73.96B |
| November 06, 2026 | 73.04B |
| November 05, 2026 | 73.50B |
| November 04, 2026 | 72.31B |
| November 03, 2026 | 69.31B |
| November 02, 2026 | 69.42B |
| October 30, 2026 | 69.23B |
| October 29, 2026 | 69.35B |
| October 28, 2026 | 68.49B |
| October 27, 2026 | 68.45B |
| October 26, 2026 | 68.82B |
| October 23, 2026 | 69.51B |
| October 22, 2026 | 69.92B |
| October 21, 2026 | 68.26B |
| October 20, 2026 | 68.12B |
| October 19, 2026 | 67.28B |
| October 16, 2026 | 67.56B |
| October 15, 2026 | 68.11B |
| October 14, 2026 | 66.78B |
| October 13, 2026 | 66.37B |
| October 12, 2026 | 66.78B |
| October 09, 2026 | 65.38B |
| Date | Value |
|---|---|
| October 08, 2026 | 65.11B |
| October 07, 2026 | 64.40B |
| October 06, 2026 | 64.44B |
| October 05, 2026 | 64.54B |
| October 02, 2026 | 63.49B |
| October 01, 2026 | 63.83B |
| September 30, 2026 | 64.09B |
| September 29, 2026 | 65.51B |
| September 28, 2026 | 66.02B |
| September 25, 2026 | 66.01B |
| September 24, 2026 | 64.76B |
| September 23, 2026 | 65.66B |
| September 22, 2026 | 65.79B |
| September 21, 2026 | 65.16B |
| September 18, 2026 | 65.23B |
| September 17, 2026 | 65.35B |
| September 16, 2026 | 65.48B |
| September 15, 2026 | 66.59B |
| September 14, 2026 | 65.77B |
| September 11, 2026 | 64.39B |
| September 10, 2026 | 64.00B |
| September 09, 2026 | 64.92B |
| September 08, 2026 | 64.73B |
| September 04, 2026 | 66.26B |
| September 03, 2026 | 67.05B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 213.21B |
| Boston Scientific Corp. | 75.60B |
| Globus Medical, Inc. | 9.182B |
| Stryker Corp. | 131.09B |
| Baxter International, Inc. | 19.33B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 696.00M |
| Revenue (Quarterly) | 5.274B |
| Total Expenses (Quarterly) | 4.578B |
| EPS Diluted (Quarterly) | 2.540 |
| Gross Profit Margin (Quarterly) | 51.06% |
| Profit Margin (Quarterly) | 13.20% |
| Earnings Yield | 1.92% |
| Operating Earnings Yield | 5.42% |
| Normalized Earnings Yield | 2.857 |